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The process of obtaining informed consent for participa-
tion in randomised controlled trials (RCTs) was estab-
lished as a mechanism to protect participants against
undue harm from research and allow people to recognise
any potential risks, or benefits, associated with the
research. A number of interventions have been put for-
ward to improve this process. Outcomes reported in trials
of interventions to improve the informed consent process
for decisions about trial participation tend to focus on
‘understanding’ of trial information and recruitment to the
parent study. Yet there is a lack of clarity regarding
whether these are the ‘right’ outcomes to measure and
which outcomes matter (to whom) and why.
The ELICIT project aims to develop a core outcome
set for the evaluation of interventions intended to
improve how people make decisions about whether to
participate in RCTs of healthcare interventions
The ELICIT project will adopt and adapt methodology
previously developed and used in projects developing core
outcome sets. Specifically, the work will consist of four
stages: 1. A systematic methodology review of existing out-
come measures of trial informed consent interventions; 2.
Interviews with key stakeholders to explore additional out-
comes relevant for trial participation decisions; 3. A Delphi
study to refine the core outcome set for evaluation of trial
informed consent interventions; and 4. A consensus group
meeting to finalise the core outcome set.
This presentation will discuss the key issues relevant
for this work and present data generated to date from
the systematic literature review, which is reviewing both
evidence from explanatory, exploratory and philosophi-
cal literature.
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